Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.02B |
| 2 |
Microsoft
MSFT
|
+$337M |
| 3 |
Apple
AAPL
|
+$308M |
| 4 |
Meta Platforms (Facebook)
META
|
+$222M |
| 5 |
Amazon
AMZN
|
+$218M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Du Pont De Nemours E I
DD
|
+$886M |
| 2 |
RAI
Reynolds American Inc
RAI
|
+$515M |
| 3 |
BHI
Baker Hughes
BHI
|
+$212M |
| 4 |
WFM
Whole Foods Market Inc
WFM
|
+$165M |
| 5 |
VCA Inc.
WOOF
|
+$97.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.56% |
| 2 | Technology | 14.64% |
| 3 | Healthcare | 13.29% |
| 4 | Industrials | 10.84% |
| 5 | Consumer Discretionary | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4076
ADMA Biologics
ADMA
$2.39B
| $33K | ﹤0.01% |
10,555
| – | – |
2017 Q1
2 quarters
|
|
4077
DELISTED
Carisma Therapeutics
CARM
| $33K | ﹤0.01% |
1,030
| – | – |
2016 Q3
4 quarters
|
|
4078
CorMedix
CRMD
$566M
| $33K | ﹤0.01% |
12,680
-13
| -0.1% | -$27 |
2014 Q1
14 quarters
|
|
4079
The ONE Group
STKS
$38.3M
| $33K | ﹤0.01% |
19,485
| – | – |
2017 Q1
2 quarters
|
|
4080
XWELL
XWEL
$7.32M
| $33K | ﹤0.01% |
20
+2
| +11% | +$3.12K |
2016 Q2
5 quarters
|
|
|
AATC
4081
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
| $33K | ﹤0.01% |
10,928
| – | – |
2017 Q1
2 quarters
|
|
|
XCO
4082
DELISTED
Exco Resources
XCO
| $33K | ﹤0.01% |
24,186
-6,855
| -22% | -$11.6K |
2013 Q2
17 quarters
|
|
4083
Harrow
HROW
$1.02B
| $32K | ﹤0.01% |
19,927
-200
| -1% | -$451 |
2015 Q3
8 quarters
|
|
4084
Urban One Class A
UONE
$19.1M
| $32K | ﹤0.01% |
1,939
-20
| -1% | -$367 |
2013 Q2
17 quarters
|
|
4085
Viking Therapeutics
VKTX
$3.2B
| $32K | ﹤0.01% |
16,962
| – | – |
2016 Q2
5 quarters
|
|
|
STLY
4086
DELISTED
Stanley Furniture Co Inc
STLY
| $32K | ﹤0.01% |
27,067
-200
| -0.7% | -$237 |
2013 Q2
17 quarters
|
|
4087
DELISTED
Charles & Colvard Ltd
CTHR
| $30K | ﹤0.01% |
3,410
| – | – |
2013 Q2
17 quarters
|
|
|
SUMR
4088
DELISTED
Summer Infant, Inc.
SUMR
| $30K | ﹤0.01% |
1,737
| – | – |
2015 Q3
8 quarters
|
|
4089
Barnwell Industries
BRN
$13.2M
| $29K | ﹤0.01% |
16,404
-200
| -1% | -$364 |
2013 Q2
17 quarters
|
|
4090
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.29B
| $29K | ﹤0.01% |
104,650
-20
| -0% | -$565 |
2013 Q2
17 quarters
|
|
4091
RF Industries
RFIL
$76.3M
| $29K | ﹤0.01% |
12,337
-15,581
| -56% | -$30K |
2013 Q2
17 quarters
|
|
4092
Cellectar Biosciences
CLRB
$10.8M
| $28K | ﹤0.01% |
5
| – | – |
2017 Q1
2 quarters
|
|
4093
Ideal Power
IPWR
$49M
| $28K | ﹤0.01% |
1,072
| – | – |
2016 Q4
3 quarters
|
|
4094
Protara Therapeutics
TARA
$137M
| $28K | ﹤0.01% |
350
-2
| -0.6% | -$114 |
2015 Q2
9 quarters
|
|
4095
DELISTED
Enservco Corp.
ENSV
| $28K | ﹤0.01% |
3,486
| – | – |
2014 Q2
13 quarters
|
|
|
MBII
4096
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $28K | ﹤0.01% |
24,737
-1
| -0% | -$1 |
2013 Q3
16 quarters
|
|
4097
DELISTED
Astria Therapeutics
ATXS
| $27K | ﹤0.01% |
210
| – | – |
2017 Q1
2 quarters
|
|
4098
Moleculin Biotech
MBRX
$5.72M
| $27K | ﹤0.01% |
5
| – | – |
2017 Q1
2 quarters
|
|
4099
Palisade Bio
PALI
$246M
| – | – |
0
| – | – |
2015 Q4
7 quarters
|
|
4100
Altimmune
ALT
$428M
| $26K | ﹤0.01% |
379
| – | – |
2013 Q2
17 quarters
|
|
Similar funds
Northern Trust's Q3 2017 Portfolio in Review
As of Q3 2017, Northern Trust held 4,364 positions worth $384B, up 7.3% from $358B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q3 2017: portfolio turnover was 4.5%. Northern Trust opened 89 new positions and exited 107, leaving the 4,364-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.
- Northern Trust's largest Q3 2017 buy was Baker Hughes: 5,053,073 shares worth $185M.
- Northern Trust added most to DuPont de Nemours in Q3 2017, an estimated $1.02B increase.
- Northern Trust's biggest Q3 2017 reduction was Northern Trust STOXX Global Broad Infrastructure ETF, cutting an estimated $73.5M.
- Northern Trust fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $886M.
- Northern Trust's ten largest holdings make up 14% of its $384B portfolio in Q3 2017.
- Northern Trust opened 89 new positions and closed 107 in Q3 2017.
- Northern Trust's portfolio value rose 7.3% quarter-over-quarter to $384B.
Based on Northern Trust's 13F filing for Q3 2017, filed 13 Nov 2017.